Abstract | BACKGROUND: METHODS: In a predefined substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP- SHOCK II) trial and its accompanying registry including patients with CS complicating AMI we investigated differences in outcome of smokers compared to non-smokers. All-cause-mortality at 1year was used as primary endpoint. RESULTS: Of 772 patients with available smoking status 263 patients were smokers (34%). Smokers were more often male (79% vs. 65%; p<0.001), of younger age (61 [interquartile range IQR 52-70] vs. 73 [IQR 64-79] years; p<0.001), had less comorbidity including arterial hypertension (62% vs. 71%; p=0.007) and diabetes mellitus (26% vs. 38%; p<0.001) and had lower levels of serum creatinine (13% vs. 25%; p<0.001). There was no significant difference between the 2 groups regarding left ventricular ejection fraction, initial revascularization strategy or use of IABP. Smokers had lower rates of mortality at 12months in univariable analysis (43% vs. 59%; p<0.001) but not after adjustment for important confounders using Cox-regression analysis (hazard ratio 0.77, 95% confidence interval 0.59-1.03; p=0.08). CONCLUSION: Smoking is not predictive of outcome in patients with CS complicating AMI. The observed survival benefit in univariable analysis seems to be explained by the younger age and lower risk profile of smokers.
|
Authors | Mohammed Saad, Georg Fuernau, Steffen Desch, Ingo Eitel, Christian Jung, Janine Pöss, Steffen Schneider, Gerhard Schuler, Karl Werdan, Uwe Zeymer, Holger Thiele |
Journal | International journal of cardiology
(Int J Cardiol)
Vol. 222
Pg. 775-779
(Nov 01 2016)
ISSN: 1874-1754 [Electronic] Netherlands |
PMID | 27521557
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Copyright | Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
Topics |
- Aged
- Female
- Germany
(epidemiology)
- Heart-Assist Devices
- Humans
- Incidence
- Intra-Aortic Balloon Pumping
- Male
- Middle Aged
- Myocardial Infarction
(complications, mortality, surgery)
- Percutaneous Coronary Intervention
(methods)
- Prognosis
- Registries
- Shock, Cardiogenic
(epidemiology, etiology, therapy)
- Smoking
(adverse effects)
- Survival Rate
(trends)
- Treatment Outcome
|